PPMD 2024 Annual Conference: Day 1 - Navigating the Approved Therapy Landscape
262 بار بازدید -
2 ماه پیش
-
Navigating the Approved Therapy Landscape:
Navigating the Approved Therapy Landscape: Rachel Schrader, MS, APRN, CPNP-PC, PPMD
Newly Approved Therapies - Agamree: Serene Nelson, PharmD, BCCCP, BCMAS, Catalyst Pharmaceuticals
Newly Approved Therapies - Duvyzat: Scott Baver, PhD, ITF Therapeutics
Newly Approved Therapies - Elevidys Expanded Label: Craig McDonald, MD, UC Davis
Current Approved Therapies Panel Discussion
Rachel Schrader, MS, APRN, CPNP-PC, PPMD (Moderator)
Aravindhan Veerapandiayn, MD, Arkansas Children's Hospital
Paula Clemens, MD, University of Pittsburgh
Omer Abdul Hamid, MD, Nemours Children's Hospital
Crystal Proud, MD, Children’s Hospital of the King’s Daughters
Diana Bharucha-Goebel, MD, PhD, Children's National Hospital
Newly Approved Therapies - Agamree: Serene Nelson, PharmD, BCCCP, BCMAS, Catalyst Pharmaceuticals
Newly Approved Therapies - Duvyzat: Scott Baver, PhD, ITF Therapeutics
Newly Approved Therapies - Elevidys Expanded Label: Craig McDonald, MD, UC Davis
Current Approved Therapies Panel Discussion
Rachel Schrader, MS, APRN, CPNP-PC, PPMD (Moderator)
Aravindhan Veerapandiayn, MD, Arkansas Children's Hospital
Paula Clemens, MD, University of Pittsburgh
Omer Abdul Hamid, MD, Nemours Children's Hospital
Crystal Proud, MD, Children’s Hospital of the King’s Daughters
Diana Bharucha-Goebel, MD, PhD, Children's National Hospital
2 ماه پیش
در تاریخ 1403/05/03 منتشر شده
است.
262
بـار بازدید شده